Vivo Opportunity Fund Holdings L.P. 13D and 13G filings for Tenax Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-14 6:47 pm Purchase | 2024-08-08 | 13G | Tenax Therapeutics, Inc. TENX | Vivo Opportunity Fund Holdings L.P. | 6,249,990 9.990% | 6,249,990 (New Position) | Filing |